The Veteran's appeal regarding the reduction of his prostate cancer disability rating from 100 percent to 40 percent was denied. The Veteran also sought an increased rating for his residuals of prostate cancer, which were denied.,A disability rating in excess of 60 percent effective June 8, 2022, for residuals of prostate cancer was denied.
The deciding factor: The reduction from a 100% to a 40% rating was proper as the Veteran's prostate cancer was found to be in remission and no longer active. The Veteran did not provide evidence showing his condition had worsened.,A disability rating in excess of 60 percent effective June 8, 2022, for residuals of prostate cancer was denied because the criteria for such a rating were not met based on the provided medical evidence.
- Claimed conditions
- Prostate Cancer
- How they argued it
- Direct service connection
- Exposure basis
- None
- Rating
- Not verified here — check the original decision
- Decision date
- July 14, 2023
- Citation
- 23039120
This is a plain-language summary generated by AI from a public Board of Veterans’ Appeals decision. It can contain errors — always verify against the original. Read the original VA decision (opens in a new tab) using citation 23039120.
What this means for you
A final Board denial may be appealed to the U.S. Court of Appeals for Veterans Claims, generally within 120 days of the Board mailing date. A Supplemental Claim with new and relevant evidence is a separate option. Another Higher-Level Review of the Board decision is not available. Check your own notice: this historical decision does not set your deadline.
What you can do next
Use your own notice and decision stage. A remanded issue is not a final court-appealable denial. VA review guidance and CAVC filing instructions (U.S. federal; reviewed October 7, 2026).
Related decisions
Other Board decisions on a similar condition or argued the same way.
- Whole decision: Granted
The Veteran is granted SMC at the rate of 50% for his service-connected conditions from April 20, 2020 to June 7, 2021.
- Whole decision: Granted
The Veteran's hypertension and prostate cancer residuals (voiding dysfunction) have been granted increased ratings of 10 percent and 20 percent, respectively.
- Whole decision: Denied
The Veteran's appeal for an increased evaluation of his depressive disorder and entitlement to a total disability rating based on individual unemployability (TDIU) is denied as the November 2024 rating decision was not adjudicating previously pursued claims.
- Whole decision: Granted
The Veteran's urinary sphincter dysfunction is restored to a 40 percent rating effective February 1, 2025. A higher rating for the condition beginning July 12, 2023, is denied.
Free starter guide for your own claim
Reading this because you were denied or under-rated? Get the plain-English next steps — your appeal options, the deadline that protects you, and how appeals like yours turn out. One email, no spam.
We will only use this to send the guide. No spam, unsubscribe any time. We never sell your information.
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.